BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhuo W, Zhang L, Cai L, Zhu B, Chen Z. XRCC1 Arg399Gln polymorphism and bladder cancer risk: updated meta-analyses based on 5767 cases and 6919 controls. Exp Biol Med (Maywood) 2013;238:66-76. [PMID: 23479765 DOI: 10.1258/ebm.2012.012209] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Mishchuk-reka Y, Kharkivska Y, Serga S, Stakhovsky E, Stakhovskyi O, Kononenko O, Koliada O, Ponomarova O, Gulkovskyi R, Ostapchenko L, Demydov S, Kozeretska I. An association of XRCC1 codon 399 polymorphism (RS25487) with bladder and prostate cancer susceptibility in the Ukrainian population. Meta Gene 2020;24:100696. [DOI: 10.1016/j.mgene.2020.100696] [Reference Citation Analysis]
2 Zeng FC, Cen S, Tang ZY, Kang XL. Elevated matrix metalloproteinase-9 expression may contribute to the pathogenesis of bladder cancer. Oncol Lett 2016;11:2213-22. [PMID: 26998151 DOI: 10.3892/ol.2016.4187] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
3 Chantre-Justino M, Alves G, Britto C, Cardoso A, Scherrer L, Moreira Ados S, Quirino R, Ornellas A, Leitão A, Lage C. Impact of reduced levels of APE1 transcripts on the survival of patients with urothelial carcinoma of the bladder. Oncol Rep 2015;34:1667-74. [PMID: 26238022 DOI: 10.3892/or.2015.4151] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
4 Chiang CI, Huang YL, Huang CY, Shiue HS, Chen WJ, Pu YS, Lin YC, Hsueh YM. XRCC1 Polymorphisms and Urinary 8-Hydroxydeoxyguanine Levels Are Associated with Urothelial Carcinoma. PLoS One 2015;10:e0124066. [PMID: 25938407 DOI: 10.1371/journal.pone.0124066] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
5 Yan J, Wang X, Tao H, Deng Z, Yang W, Lin F. Meta-Analysis of the Relationship between XRCC1-Arg399Gln and Arg280His Polymorphisms and the Risk of Prostate Cancer. Sci Rep 2015;5:9905. [PMID: 25927275 DOI: 10.1038/srep09905] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
6 Akhmadishina LZ, Gilyazova IR, Kutlyeva LR, Korytina GF, Kochetova OV, Urmantsev MF, Izmailova SM, Izmailov AA, Kunsbaeva GB, Zagidullin AA, Khaliullin AA, Pavlov VN, Victorova TV, Khusnutdinova EK. DNA repair XPCC1 and XPD genes polymorphism as associated with the development of bladder cancer and renal cell carcinoma. Russ J Genet 2014;50:421-9. [DOI: 10.1134/s1022795414040024] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
7 Porru S, Pavanello S, Carta A, Arici C, Simeone C, Izzotti A, Mastrangelo G. Complex relationships between occupation, environment, DNA adducts, genetic polymorphisms and bladder cancer in a case-control study using a structural equation modeling. PLoS One 2014;9:e94566. [PMID: 24722645 DOI: 10.1371/journal.pone.0094566] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
8 Mishchuk YM, Kharkivska YV, Serha SV, Shkliar SY, Katrii VB, Koliada OK, Stakhovskyi OE, Stakhovskyi EO, Vitruk YV, Kononenko AA, Demydov SV, Ostapchenko LI, Kozeretska IA. XRCC1 codon 399 polymorphism (RS25487) in the Ukrainian population. Fakt eksp evol org 1970;21:325-329. [DOI: 10.7124/feeo.v21.861] [Reference Citation Analysis]